Colgate-Palmolive Announces Quarterly Dividend of $0.45 (NYSE:CL)

Colgate-Palmolive (NYSE:CL) announced a quarterly dividend on Thursday, June 10th, RTT News reports. Investors of record on Wednesday, July 21st will be paid a dividend of 0.45 per share on Monday, August 16th. This represents a $1.80 annualized dividend and a yield of 2.15%.

Shares of CL opened at $83.60 on Friday. The company’s 50 day simple moving average is $81.83. The company has a market cap of $70.72 billion, a P/E ratio of 26.97, a PEG ratio of 4.26 and a beta of 0.61. Colgate-Palmolive has a 12-month low of $71.21 and a 12-month high of $86.41. The company has a debt-to-equity ratio of 11.42, a current ratio of 1.01 and a quick ratio of 0.64.

Colgate-Palmolive (NYSE:CL) last issued its earnings results on Thursday, April 29th. The company reported $0.80 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.79 by $0.01. The company had revenue of $4.34 billion for the quarter, compared to the consensus estimate of $4.28 billion. Colgate-Palmolive had a return on equity of 298.80% and a net margin of 15.92%. The firm’s quarterly revenue was up 6.0% on a year-over-year basis. During the same quarter last year, the company earned $0.75 EPS. On average, equities research analysts predict that Colgate-Palmolive will post 3.28 EPS for the current year.

CL has been the subject of several research analyst reports. JPMorgan Chase & Co. cut their price target on Colgate-Palmolive from $87.00 to $85.00 and set a “neutral” rating for the company in a report on Friday, April 16th. Credit Suisse Group upgraded Colgate-Palmolive from a “neutral” rating to an “outperform” rating and raised their price target for the company from $80.00 to $95.00 in a report on Wednesday. Deutsche Bank Aktiengesellschaft raised their price target on Colgate-Palmolive from $84.00 to $85.00 and gave the company a “hold” rating in a report on Monday, May 3rd. Finally, Zacks Investment Research upgraded Colgate-Palmolive from a “sell” rating to a “hold” rating and set a $85.00 price target for the company in a report on Monday, May 3rd. Two equities research analysts have rated the stock with a sell rating, seven have assigned a hold rating and two have assigned a buy rating to the company’s stock. The stock currently has a consensus rating of “Hold” and a consensus target price of $84.42.

In related news, insider John W. Kooyman sold 11,195 shares of the firm’s stock in a transaction that occurred on Thursday, May 6th. The stock was sold at an average price of $82.07, for a total transaction of $918,773.65. Following the completion of the sale, the insider now directly owns 19,251 shares of the company’s stock, valued at approximately $1,579,929.57. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, CTO Patricia Verduin sold 46,566 shares of the firm’s stock in a transaction that occurred on Wednesday, May 5th. The stock was sold at an average price of $80.89, for a total value of $3,766,723.74. Following the sale, the chief technology officer now directly owns 100,680 shares of the company’s stock, valued at $8,144,005.20. The disclosure for this sale can be found here. In the last quarter, insiders sold 91,040 shares of company stock valued at $7,384,255. Company insiders own 0.32% of the company’s stock.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products worldwide. The company operates through two segments, Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment's products include toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other similar items.

Further Reading: Stock Selection – What is cash flow?

Dividend History for Colgate-Palmolive (NYSE:CL)

Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.